Publicly available transcriptomic datasets were integrated with multiplex immunohistochemistry on colon cancer tissue microarrays to characterize the cell-type-specific distribution of CD82 and its associations with key markers of T cell dysfunction. This evidence concerns the gene CD82 and colonic neoplasm.